Evaluation of the local anesthetic ropivacaine versus lidocaine to control pain in lower wisdom extraction.

Ropivacaine in its pure formula versus lidocaine for pain control associated to the removal of included lower third molars- a randomized double blind clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-7wyqr7

Enrollment

Unknown

Registered

2017-05-19

Start date

2016-04-10

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Third molar even

Interventions

Extraction of the lower third molar included with use of local anesthetic where each patient is self-control. Group 1 with 16 patients being anesthetized in the first extraction with lidocaine. In a s

Drug

Procedure/surgery

E06.892

E03.155.141

Eligibility

Inclusion criteria

Inclusion criteria: Lower third molars included with the same classification according to Pearl & Gregory, in the same patient; agree to TCLE; Be patient at the outpatient clinic of Buco Surgery Maxilo Facial of University Hospital of Brasília.

Exclusion criteria

Exclusion criteria: Lower third molars included with different rankings according to Pearl & Gregory, in the same patient; follow guidelines different from those provided by the researcher.

Design outcomes

Primary

Measure	Time frame
Local anesthetic ropivacaine provides better postoperative pain control, which will be measured through VAS. We expect better pain control when we use ropivacaine over lidocaine.	—

Secondary

Measure	Time frame
Secondary outcomes are not expected	—

Countries

Brazil

Contacts

Public ContactHugo Cunha

Faculdade de Ciências da Saúde

hugo.uniface@gmail.com+55 61 99223 0509

Outcome results

None listed

Source: REBEC (via WHO ICTRP)